Fintel reports that on May 18, 2026, Freedom Broker upgraded their outlook for Atara Biotherapeutics (NasdaqGS:ATRA) from Sell to Hold. Analyst Price Forecast Suggests 29.49% Upside As of May 14, 2026 ...

ATRA) on Tuesday reported a first-quarter loss of $4.1 million, after reporting a profit in the same period a year earlier. The Thousand Oaks, California-based company said it had a loss of 29 cents ...

Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients ...

The Gross Law Firm issues the following notice to shareholders of Atara Biotherapeutics, Inc. (NASDAQ: ATRA). Shareholders who purchased shares of ATRA during the class period listed are encouraged to ...

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Atara Biotherapeutics, Inc. ("Atara" or the "Company") and reminds investors of the May 22, 2026 ...

The average one-year price target for Atara Biotherapeutics (NasdaqGS:ATRA) has been revised to $11.90 / share. This is an increase of 25.00% from the prior estimate of $9.52 dated April 25, 2026. The ...

Swedish-Mexican design studio ATRA and French textile brand Métaphores present Cosmo Nova, a collaborative furniture collection launched within an exhibition for NYCxDesign 2026. Informed by satellite ...

SPAR Norway has expanded its network with two new partially remote-controlled stores: SPAR Prestfoss and SPAR Sæbøvik.

Pomerantz LLP is investigating claims on behalf of investors of Bakkt, Inc. ("Bakkt" or the "Company") . Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ...

Saat itu bus PO Haryanto berhenti 100 meter dari posisi korban kecelakaan, untuk menghindar kecelakaan beruntun, mengingat ...